Literature DB >> 9519185

Improving management of duodenal ulcer disease.

M C Bateson1, B L Diffey.   

Abstract

Audit of treatment of duodenal ulcer disease has allowed management to improve and keep abreast of rapid advances in care. Eradication of Helicobacter pylori was assessed by 14C urea breath test one to two months after anti-Helicobacter therapy. The old triple therapy regime of bismuth, tetracycline and metronidazole for two weeks was found to be toxic and of low effectiveness (82%). Regimes with lansoprazole for one month and antibiotics for one week gave 90-98% success rates. The best success has been with regimes containing both clarithromycin and a nitro-imidazole. There was complete success in 98% of 109 patients given quadruple therapy with lansoprazole 30 mg daily for one month plus tetracycline 500 mg twice daily, clarithromycin 250 mg twice daily and metronidazole 400 mg twice daily for one week.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9519185      PMCID: PMC2431568          DOI: 10.1136/pgmj.73.865.717

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  10 in total

1.  The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients.

Authors:  K E McColl; A el-Nujumi; L Murray; E el-Omar; D Gillen; A Dickson; A Kelman; T E Hilditch
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  A 20-minute breath test for helicobacter pylori.

Authors:  B J Marshall; M W Plankey; S R Hoffman; C L Boyd; K R Dye; H F Frierson; R L Guerrant; R W McCallum
Journal:  Am J Gastroenterol       Date:  1991-04       Impact factor: 10.864

3.  Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori.

Authors:  A V Thillainayagam; A S Arvind; R S Cook; I G Harrison; S Tabaqchali; M J Farthing
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

4.  Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; J Reid; P Boothmann; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

Review 5.  Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease.

Authors:  J G Penston
Journal:  Aliment Pharmacol Ther       Date:  1996-08       Impact factor: 8.171

6.  Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection.

Authors:  W de Boer; W Driessen; A Jansz; G Tytgat
Journal:  Lancet       Date:  1995-04-01       Impact factor: 79.321

7.  Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens.

Authors:  G D Bell; K U Powell; S M Burridge; A N Bowden; B Rameh; G Bolton; K Purser; G Harrison; C Brown; P W Gant
Journal:  Q J Med       Date:  1993-11

Review 8.  Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence.

Authors:  G N Tytgat
Journal:  Aliment Pharmacol Ther       Date:  1994-08       Impact factor: 8.171

9.  High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication.

Authors:  M Dalla Libera; P Pazzi; G Carli; S Gamberini; R Scagliarini; A Merighi; S Gullini
Journal:  Aliment Pharmacol Ther       Date:  1996-04       Impact factor: 8.171

Review 10.  Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review.

Authors:  R J Hopkins; L S Girardi; E A Turney
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

  10 in total
  3 in total

Review 1.  Helicobacter pylori.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

2.  Treatment of Helicobacter pylori infection. Development of resistance to antibiotics used must be avoided.

Authors:  G G Rao; J O'Donohue; C S Mahankali Rao; H Fidler
Journal:  BMJ       Date:  2000-06-03

3.  Quadruple therapy for symptomatic spontaneous duodenal ulcer disease.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.